0% found this document useful (0 votes)
2 views9 pages

MAli Assignment

The document discusses cardiac glycosides, particularly Digoxin, which improves heart function and is used for conditions like heart failure and atrial fibrillation. It outlines the effects of cardiovascular drugs, including ionotropic, chronotropic, and dromotropic effects, as well as the management of Digoxin toxicity and arrhythmias through various anti-arrhythmic drug classes. Additionally, it emphasizes nursing care and monitoring for patients on these medications.

Uploaded by

jawadkhancom39
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
2 views9 pages

MAli Assignment

The document discusses cardiac glycosides, particularly Digoxin, which improves heart function and is used for conditions like heart failure and atrial fibrillation. It outlines the effects of cardiovascular drugs, including ionotropic, chronotropic, and dromotropic effects, as well as the management of Digoxin toxicity and arrhythmias through various anti-arrhythmic drug classes. Additionally, it emphasizes nursing care and monitoring for patients on these medications.

Uploaded by

jawadkhancom39
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

Name :

1) M. Ali S/o Altaf hussain


2) Mehak wali
3) Mehak Faraz
4) Muddasir

Cardiac Glycosides and Anti-Arrhythmic Drugs

Introduction

Cardiac glycosides are drugs used to improve the pumping ability of the
heart. The most commonly used cardiac glycoside is Digoxin. Anti-arrhythmic
drugs are medications used to treat abnormal heart rhythms (arrhythmias)
and restore normal cardiac conduction.

Ionotropic, Chronotropic, and Dromotropic Effects of Cardiovascular Drugs

1. Ionotropic Effect

The ionotropic effect refers to the force of cardiac muscle contraction.

- Positive ionotropic effect: Increases the force of contraction (e.g., Digoxin).

- Negative ionotropic effect: Decreases the force of contraction.

2. Chronotropic Effect
The chronotropic effect refers to the heart rate.

- Positive chronotropic effect: Increases heart rate.

- Negative chronotropic effect: Decreases heart rate.

3. Dromotropic Effect

The dromotropic effect refers to the conduction of electrical impulses through


the heart.

- Positive dromotropic effect: Increases conduction velocity.

- Negative dromotropic effect: Decreases conduction velocity.

Digoxin

Therapeutic Effects and Uses of Digoxin

Digoxin is a cardiac glycoside that increases myocardial contractility and


improves cardiac output.

Uses:

1. Heart failure.

2. Atrial fibrillation.

3. Atrial flutter.

4. Supraventricular tachycardia.
Therapeutic Effects:

- Increases cardiac output.

- Reduces heart rate.

- Improves circulation.

- Decreases edema and shortness of breath.

- Improves exercise tolerance.

Digitalization

Digitalization is the process of administering Digoxin in loading doses to


rapidly achieve therapeutic drug levels in the body.

Purpose:

- To quickly obtain the desired therapeutic effect.

- Commonly used in severe heart failure and certain arrhythmias.

Digoxin Toxicity

Early Signs and Symptoms

- Loss of appetite

- Nausea

- Vomiting

- Fatigue

- Weakness
- Abdominal discomfort

Moderate Toxicity

- Blurred vision

- Yellow-green vision (xanthopsia)

- Headache

- Dizziness

- Bradycardia

- Irregular pulse

Severe Toxicity

- Severe arrhythmias

- Heart block

- Ventricular tachycardia

- Ventricular fibrillation

- Confusion

- Syncope

- Cardiac arrest

Nursing Care Related to Digoxin Toxicity

1. Monitor pulse rate before administration.

2. Withhold Digoxin if heart rate is below prescribed limits.

3. Monitor ECG changes.

4. Assess serum Digoxin levels regularly.


5. Monitor serum potassium levels.

6. Observe for signs of toxicity.

7. Educate patients about symptoms of toxicity.

8. Report toxicity immediately.

9. Administer Digoxin immune Fab as prescribed in severe toxicity.

Pharmacological Management of Arrhythmias

Management depends on the type of arrhythmia and may include:

- Anti-arrhythmic drugs

- Electrical cardioversion

- Defibrillation

- Pacemaker therapy

- Catheter ablation

Goals of treatment:

- Restore normal rhythm.

- Control ventricular rate.

- Prevent complications.

Anti-Arrhythmic Drugs

Anti-arrhythmic drugs are classified according to the Vaughan-Williams


classification.
Class I: Sodium Channel Blockers

Examples:

- Quinidine

- Procainamide

- Lidocaine

Mechanism of Action:

Block sodium channels and slow impulse conduction.

Indications:

- Ventricular arrhythmias

- Supraventricular arrhythmias

Adverse Effects:

- Hypotension

- Dizziness

- Nausea

- Proarrhythmia

Class II: Beta Blockers

Examples:
- Metoprolol

- Propranolol

- Atenolol

Mechanism of Action:

Block beta-adrenergic receptors and reduce sympathetic stimulation.

Indications:

- Atrial fibrillation

- Supraventricular tachycardia

Adverse Effects:

- Bradycardia

- Fatigue

- Hypotension

Class III: Potassium Channel Blockers

Examples:

- Amiodarone

- Sotalol

Mechanism of Action:

Prolong repolarization and action potential duration.


Indications:

- Ventricular tachycardia

- Atrial fibrillation

Adverse Effects:

- Pulmonary toxicity

- Thyroid dysfunction

- Bradycardia

Class IV: Calcium Channel Blockers

Examples:

- Verapamil

- Diltiazem

Mechanism of Action:

Slow conduction through the AV node.

Indications:

- Supraventricular tachycardia

- Atrial fibrillation
Adverse Effects:

- Bradycardia

- Hypotension

- Constipation

Pharmacokinetics of Anti-Arrhythmic Drugs

- Absorption: Most are absorbed orally.

- Distribution: Widely distributed throughout the body.

- Metabolism: Mainly metabolized in the liver.

- Excretion: Eliminated through kidneys or bile depending on the drug.

Nursing Implications of Anti-Arrhythmic Drugs

1. Monitor ECG continuously.

2. Assess heart rate and blood pressure regularly.

3. Observe for signs of arrhythmias.

4. Monitor electrolyte levels.

5. Educate patients regarding medication adherence.

6. Monitor for adverse effects and drug interactions.

7. Assess liver and kidney function.

8. Encourage patients to report dizziness, chest pain, or palpitations


immediately.

You might also like